Home » Topics » BioWorld Science, Conferences

BioWorld Science, Conferences
RSS

Eisai develops novel lanosterol synthase inhibitor for HCV

Nov. 17, 2011

TGase-2 correlated with reduced survival in lung cancer

Nov. 16, 2011

BIIB-023 demonstrates favorable safety and tolerability profile in rheumatoid arthritis trial

Nov. 16, 2011

Chemokine as proinflammatory signal after traumatic brain injury

Nov. 16, 2011

PBI-4050 demonstrates nephroprotection in animal models

Nov. 16, 2011

AMG-145 assessed in first-in-human trial

Nov. 16, 2011

Phase II results reported for miravirsen

Nov. 16, 2011

Phase III trial of vorapaxar does not meet primary endpoint

Nov. 15, 2011

Cancer therapy Lipotecan advances through first-in-human trial

Nov. 15, 2011

Novel voltage-gated K(V)7 potassium channel modulator has anticonvulsant activity

Nov. 15, 2011

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for April 17, 2026.
Biohaven reports details on discovery of BHV-2100
BioWorld Science
Transient receptor potential melastatin 3 (TRPM3) is a calcium-permeable TRP channel that is highly expressed in somatosensory neurons, including nociceptors of...
Meta-analysis: Anti-amyloid Alzheimer’s drugs not ‘clinically meaningful’
BioWorld
The ongoing controversy over the effectiveness of anti-amyloid drugs is about to get more heated, after a review of clinical trials showed statistically...
News in brief
BioWorld Asia
BioWorld Asia briefs for April 14, 2026
Novel caspase-2 inhibitor shows in vivo neuroprotective effects
BioWorld Science
Caspase-2-mediated cleavage of tau at Asp314 generates a neurotoxic fragment, Δtau314, that drives early synaptic dysfunction in Alzheimer’s disease (AD) and...